Successful Management of Extensively Drug Resistant Pseudomonas aeruginosa-Infectious Scleritis after Pterygium Surgery

被引:0
|
作者
Dalal, Samruddhi [1 ]
Murthy, Somasheila, I [1 ,5 ]
Deogaokar, Ketan [1 ]
Joseph, Joveeta [2 ,3 ]
Roy, Sanhita [3 ,4 ]
机构
[1] L V Prasad Eye Inst, Cornea Inst, Cornea Serv, Hyderabad, India
[2] LV Prasad Eye Inst, Jhaveri Microbiol Ctr, Hyderabad, India
[3] LV Prasad Eye Inst, Ramoji Fdn Ctr Ocular Infect, Hyderabad, India
[4] LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Brien Holden Eye Res Ctr, Hyderabad, India
[5] L V Prasad Eye Inst, Cornea Inst, Kallam Anji Reddy Campus,LV Prasad Marg,Banjara Hi, Hyderabad 500034, India
关键词
Drug-resistant Pseudomonas aeruginosa; infectious scleritis; pterygium surgery-infectious scleritis; colistin eye drops; management of Pseudomonas scleritis; BACTERIAL;
D O I
10.1080/09273948.2023.2232037
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction and purposeWe report a case of extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) scleritis after pterygium surgery.MethodsCase report.ResultsA 58-year-old farmer presented with a 40-day history of severe pain, swelling, and blurred vision after a pterygium excision was performed at another institute. The patient was on multiple medications with no relief. The examination showed a nasally located scleral thinning in his right eye, with ulceration and infiltrates. Microbiology revealed Pseudomonas aeruginosa, which showed intermediate sensitivity to colistin only. The patient was administered topical (0.19%) and intravenous colistin and dexamethasone. There was a rapid reduction in symptoms, and the lesions healed over the next 2 months.ConclusionsTo the best of our knowledge, this is the first case report of XDR-PA scleritis. We suggest the possibility of evolving drug resistance caused by the iatrogenic use of antibiotics during the early stages of the disease course.
引用
收藏
页码:1279 / 1283
页数:5
相关论文
共 50 条
  • [31] Extensively drug-resistant Pseudomonas aeruginosa panophthalmitis from contaminated artificial tears
    Wang, Taylor
    Jain, Sumeet
    Glidai, Yoav
    Dua, Prachi
    Dempsey, Katharine S.
    Shakin, Eric
    Chu, David S.
    Epstein, Marcia
    Ha, Lawrence G.
    IDCASES, 2023, 33
  • [32] Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia
    Khawcharoenporn, Thana
    Chuncharunee, Alan
    Maluangnon, Chailat
    Taweesakulvashra, Thitiporn
    Tiamsak, Pimsiri
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (06) : 828 - 834
  • [33] Successful Management of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia after Kidney Transplantation in a Dog
    Park, Kyung-Mee
    Nam, Hyun-Suk
    Woo, Heung-Myong
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2013, 75 (11): : 1529 - 1533
  • [34] Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer
    Krajewski, Jochen
    Bode-Boeger, Stefanie M.
    Troeger, Uwe
    Martens-Lobenhoffer, Jens
    Mulrooney, Thomas
    Mittelstaedt, Hagen
    Russlies, Martin
    Kirchner, Rainer
    Knobloch, Johannes K. -M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (04) : 363 - 366
  • [35] Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa
    Brookfield, Charlotte
    Fadden, Emma
    Sweeney, Louise
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (05):
  • [36] Dissemination of High-Risk Clones of Extensively Drug-Resistant Pseudomonas aeruginosa in Colombia
    Correa, Adriana
    del Campo, Rosa
    Perenguez, Marcela
    Blanco, Victor M.
    Rodriguez-Banos, Mercedes
    Perez, Federico
    Maya, Juan J.
    Rojas, Laura
    Canton, Rafael
    Arias, Cesar A.
    Villegas, Maria V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2421 - 2425
  • [37] Draft Genome Sequence of a Clinically Isolated Extensively Drug-Resistant Pseudomonas aeruginosa Strain
    Manivannan, Bhavani
    Mahalingam, Niranjana
    Jadhao, Sudhir
    Mishra, Amrita
    Nilawe, Pravin
    Pradeep, Bulagonda Eswarappa
    GENOME ANNOUNCEMENTS, 2016, 4 (02)
  • [38] Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis
    Funiciello, Elisa
    Mula, Jacopo
    Mignone, Federica
    Silvestro, Erika
    Ragazzi, Paola
    Pilloni, Giulia
    Costa, Cristina
    D'Avolio, Antonio
    Garazzino, Silvia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2776 - 2778
  • [39] Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain
    del Barrio-Tofino, Ester
    Lopez-Causape, Carla
    Cabot, Gabriel
    Rivera, Alba
    Benito, Natividad
    Segura, Concepcion
    Milagro Montero, Maria
    Sorli, Luisa
    Tubau, Fe
    Gomez-Zorrilla, Silvia
    Tormo, Nuria
    Dura-Navarro, Raquel
    Viedma, Esther
    Resino-Foz, Elena
    Fernandez-Martinez, Marta
    Gonzalez-Rico, Claudia
    Alejo-Cancho, Izaskun
    Antonio Martinez, Jose
    Labayru-Echverria, Cristina
    Duenas, Carlos
    Ayestaran, Ignacio
    Zamorano, Laura
    Martinez-Martinez, Luis
    Pablo Horcajada, Juan
    Oliver, Antonio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
  • [40] Cefiderocol is an effective topical monotherapy for experimental extensively -drug resistant Pseudomonas aeruginosa keratitis.
    Romanowski, Eric G.
    Mumper, Sonya M.
    Shanks, Hazel Q.
    Yates, Kathleen A.
    Mandell, Jonathan B.
    Zegans, Michael E.
    Shanks, Robert M. Q.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)